for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Neubase Therapeutics Inc

NBSE.O

Latest Trade

8.06USD

Change

0.06(+0.75%)

Volume

170,267

Today's Range

7.73

 - 

8.31

52 Week Range

4.15

 - 

11.78

As of on the NASDAQ ∙ Minimum 15 minute delay

Officers & DirectorsAs of

NameAgePositionAppointed
Dietrich A. Stephan
President, Chief Executive Officer, Director
50President, Chief Executive Officer, Director2019
Sam Backenroth
Chief Financial Officer, Treasurer, Secretary
35Chief Financial Officer, Treasurer, Secretary2019
William Mann
Chief Operating Officer
60Chief Operating Officer2020
Dov A. Goldstein
Independent Director
52Independent Director2019
Diego Diego Miralles
Independent Director
57Independent Director2019
Franklyn G. Prendergast
Independent Director
74Independent Director2019
Eric I. Richman
Independent Director
--Independent Director2019

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up